KEGG: ses:SARI_03782
STRING: 882884.SARI_03782
ATP synthase subunit b, encoded by the atpF gene in Salmonella arizonae, is a critical component of the F1Fo ATP synthase complex. This subunit forms part of the peripheral stalk (also called the stator) of the enzyme complex, connecting the membrane-embedded Fo sector to the catalytic F1 sector. The primary function of subunit b is structural - it helps maintain the integrity of the ATP synthase complex during rotational catalysis.
In Salmonella, the ATP synthase complex couples proton translocation across the bacterial membrane to ATP synthesis/hydrolysis. Research has shown that the F1Fo ATP synthase is required for virulence in Salmonella, as it helps maintain physiological ATP levels and cytoplasmic pH . The b subunit specifically contributes to the stability of this complex, allowing efficient energy conversion during bacterial metabolism and infection processes.
The ATP synthase subunit b (atpF) differs from other subunits in several important structural and functional aspects. Structurally, atpF forms an elongated, predominantly alpha-helical protein that spans from the membrane to the top of the F1 sector. Unlike the catalytic subunits (α, β) in the F1 sector that directly participate in ATP synthesis, or the c-ring subunits that facilitate proton translocation in the Fo sector, the b subunit primarily serves as a structural component.
Functionally, while subunit a (atpB) in the Fo sector forms part of the proton channel and interacts with regulatory proteins like MgtC , subunit b does not directly participate in proton translocation or ATP synthesis. Instead, it transmits conformational changes between the Fo and F1 sectors and prevents the F1 sector from rotating with the c-ring during catalysis, which is essential for the conversion of the proton gradient energy into chemical energy in the form of ATP.
The F1Fo ATP synthase plays a critical role in Salmonella pathogenicity through multiple mechanisms that support bacterial survival and replication within host environments:
Energy metabolism: ATP synthase is essential for energy generation, particularly under the nutrient-limited conditions encountered within host cells.
pH homeostasis: Research demonstrates that F1Fo ATP synthase helps maintain cytoplasmic pH in Salmonella, which is crucial for survival in the acidic environment of phagosomes .
Interaction with virulence factors: Evidence shows that virulence proteins such as MgtC interact with the ATP synthase complex (specifically with subunit a) to modulate its activity. This interaction inhibits ATP-driven proton translocation and NADH-driven ATP synthesis, helping maintain physiological ATP levels during infection .
Survival in macrophages: The regulation of ATP synthase activity is critical for Salmonella survival within macrophages, a key step in establishing systemic infection .
Mutations affecting ATP synthase function can significantly attenuate Salmonella virulence, highlighting its importance in pathogenicity and potential as a target for therapeutic intervention.
Research has revealed sophisticated interactions between bacterial virulence factors and ATP synthase components that significantly impact Salmonella pathogenicity. The virulence protein MgtC, required for survival within macrophages and lethal infection in mice, directly interacts with the a subunit (atpB) of the F1Fo ATP synthase . This interaction inhibits ATP-driven proton translocation and NADH-driven ATP synthesis.
The functional consequences of this interaction include:
Reduced ATP hydrolysis: Vesicles from wild-type Salmonella release less phosphate than those from mgtC mutants, indicating inhibited ATP hydrolysis .
Maintained physiological ATP levels: Wild-type Salmonella maintains lower ATP levels compared to mgtC mutants, which display ~2.2-fold higher ATP levels .
Cytoplasmic pH regulation: The interaction helps maintain appropriate cytoplasmic pH, which is crucial within the acidic phagosomal environment .
A single amino acid substitution (N92T) in MgtC prevents interaction with the F1Fo ATP synthase and compromises these phenotypes, demonstrating the specificity and importance of this interaction . While these interactions have been documented for subunit a, further research is needed to determine if similar interactions occur with the b subunit (atpF) or if modifying atpF could affect these interactions indirectly by altering complex structure or function.
When designing experiments to study recombinant atpF, researchers should consider several critical factors:
Expression system selection:
Homologous vs. heterologous expression systems
Impact of expression tags on structure and function
Membrane protein expression challenges
Purification strategy:
Detergent selection for membrane protein extraction
Maintaining structural integrity during purification
Assessing protein folding and oligomerization state
Functional assays:
ATP synthesis/hydrolysis measurements
Proton translocation assays
Protein-protein interaction studies
Mutation analysis:
Selection of residues for site-directed mutagenesis
Assessing impact on complex assembly
Evaluating effects on function and interactions
Physiological relevance:
Correlation between in vitro and in vivo findings
Assessment in bacterial infection models
Validation in different Salmonella strains
The experimental design should account for the membrane-associated nature of atpF and its role within a multi-subunit complex. Researchers should also consider how modifications to atpF might affect interactions with other ATP synthase subunits and potentially with virulence factors like MgtC that are known to target the ATP synthase complex .
Structural studies of ATP synthase subunit b can provide critical insights into Salmonella virulence mechanisms through several approaches:
Identification of interaction interfaces: Determining the precise structural regions of atpF that interact with other ATP synthase subunits and potential virulence factors can reveal mechanisms of regulatory control during infection.
Conformational dynamics: Analyzing structural changes in atpF during different functional states of ATP synthase can elucidate how energy generation is modulated during infection.
Comparative structural biology: Comparing atpF structures across different bacterial species can identify Salmonella-specific features that might contribute to its unique pathogenicity.
Structure-guided drug design: Detailed structural information can facilitate the development of inhibitors that specifically target Salmonella ATP synthase, potentially leading to new antimicrobial strategies.
Understanding complex assembly: Structural studies can reveal how atpF contributes to the assembly and stability of the ATP synthase complex, which is essential for bacterial energy metabolism during infection.
Expressing and purifying recombinant Salmonella atpF requires specialized protocols due to its membrane-associated nature. Based on successful approaches with ATP synthase components, the following methodological framework is recommended:
Expression System Selection:
E. coli C41(DE3) or C43(DE3) strains are preferred for membrane protein expression
pET-based vectors with T7 promoter provide controllable, high-level expression
C-terminal His6-tag facilitates purification while minimizing functional interference
Expression Protocol:
Transform expression plasmid into host strain
Culture in LB medium at 37°C until OD600 reaches 0.6-0.8
Induce with 0.1-0.5 mM IPTG
Reduce temperature to 18-25°C post-induction
Continue expression for 12-16 hours
Membrane Preparation:
Harvest cells by centrifugation (5,000×g, 15 min, 4°C)
Resuspend in buffer (50 mM Tris-HCl pH 8.0, 100 mM NaCl, 5 mM MgCl2)
Disrupt cells using French press or sonication
Remove cell debris by centrifugation (10,000×g, 20 min, 4°C)
Collect membranes by ultracentrifugation (150,000×g, 1 hour, 4°C)
Purification Strategy:
Solubilize membranes with appropriate detergent (n-dodecyl-β-D-maltoside at 1% is often effective)
Perform immobilized metal affinity chromatography using Ni-NTA
Include size exclusion chromatography as a polishing step
Maintain protein in buffer containing 0.05% detergent to prevent aggregation
Quality Assessment:
SDS-PAGE for purity evaluation
Western blotting for identity confirmation
Circular dichroism to assess secondary structure
Dynamic light scattering for homogeneity analysis
This methodology can be adapted for co-expression with other ATP synthase subunits if studying the assembled complex is desired.
Multiple complementary techniques can effectively characterize interactions between ATP synthase subunit b and other bacterial proteins:
In vitro Interaction Assays:
Co-immunoprecipitation (Co-IP):
Pull-down Assays:
Using recombinant His-tagged atpF as bait
Useful for confirming direct interactions
Can be coupled with mass spectrometry for unbiased identification of binding partners
Surface Plasmon Resonance (SPR):
Provides real-time binding kinetics
Requires immobilization of one protein partner
Can determine association/dissociation constants
In vivo Interaction Methods:
Bacterial Two-Hybrid System:
Adapted for membrane proteins using split-ubiquitin approach
Allows screening for interactions in a cellular context
Förster Resonance Energy Transfer (FRET):
Detects interactions between fluorescently labeled proteins
Particularly valuable for dynamic interaction studies in living cells
Cross-linking Coupled with Mass Spectrometry:
Captures transient interactions
Identifies specific interaction interfaces
Has been effective for mapping ATP synthase subunit interactions
Structural Approaches:
Cryo-electron Microscopy:
Visualizes protein complexes in near-native state
Increasingly powerful for membrane protein complexes
X-ray Crystallography:
Provides atomic-level details of interaction interfaces
Challenging for membrane proteins but possible with advanced techniques
When applying these methods, researchers should consider controls to verify specificity, such as using point mutations that disrupt interactions (as demonstrated with the MgtC N92T variant that failed to interact with the F1Fo ATP synthase ).
Designing effective mutation studies for ATP synthase subunit b requires a systematic approach that integrates structural information, sequence conservation analysis, and functional considerations:
Strategic Planning for Mutation Studies:
Sequence-based Selection:
Perform multiple sequence alignment across bacterial species
Identify highly conserved residues as potential functional hotspots
Analyze Salmonella-specific residues that may contribute to unique functions
Structure-guided Approaches:
Target residues at interfaces with other subunits
Focus on regions predicted to be important for stator function
Consider the transmembrane domain, which anchors the protein
Mutation Design Principles:
Conservative substitutions (e.g., Leu→Ile) to test structural roles
Non-conservative substitutions (e.g., charged→uncharged) to test functional roles
Alanine-scanning for systematic functional mapping
Cysteine substitutions for accessibility and cross-linking studies
Experimental Verification Workflow:
| Mutation Category | Examples | Primary Assays | Secondary Assays |
|---|---|---|---|
| Transmembrane domain | L16A, I20A, V24A | ATP synthesis activity | Membrane integration |
| Dimerization interface | L72K, V76D, I80K | Complex assembly | Protein stability |
| F1 interaction sites | R122A, E126Q, R130A | ATP hydrolysis | Proton pumping |
| Potential regulatory sites | Based on homology with known sites | Growth phenotypes | Protein-protein interactions |
Controls and Validation:
Include wild-type controls in all experiments
Verify expression levels of mutant proteins
Assess protein stability and complex assembly
Consider genomic replacements to maintain native expression levels
This strategic approach has proven effective in other ATP synthase subunits, as demonstrated by the N92T mutation in MgtC that abolished interaction with ATP synthase and compromised Salmonella pathogenicity .
Interpreting changes in ATP synthase activity in atpF mutants requires careful consideration of multiple parameters and potential indirect effects:
Primary Activity Parameters:
ATP Synthesis Rate:
Decreased synthesis rates may indicate structural destabilization of the complex
Complete loss of activity suggests critical functional role or complex assembly failure
Increased rates might indicate relief from regulatory constraints
ATP Hydrolysis Activity:
Proton Translocation Efficiency:
Interpretation Framework:
| Phenotype Observed | Potential Interpretations | Additional Tests Recommended |
|---|---|---|
| Decreased ATP synthesis without affecting hydrolysis | Disruption of conformational coupling | Proton gradient formation assays |
| Decreased stability of ATP synthase complex | Disruption of inter-subunit interactions | Co-immunoprecipitation, BN-PAGE |
| Normal enzymatic activity but altered regulation | Disruption of regulatory protein interactions | Protein-protein interaction assays with known regulators |
| Decreased membrane association | Disruption of membrane anchoring | Membrane fractionation studies |
Contextual Considerations:
Expression Level Effects:
Ensure mutant protein is expressed at levels comparable to wild-type
Consider using genomic replacements rather than plasmid-based expression
Complex Assembly:
Assess whether detected phenotypes result from impaired assembly rather than direct functional effects
Blue Native PAGE can evaluate intact complex formation
Physiological Context:
Interpret biochemical findings in context of bacterial growth phenotypes
Consider phenotypes under different energy source conditions
Evaluate impacts on virulence in infection models
This methodical approach to interpretation helps distinguish direct functional effects from secondary consequences and provides mechanistic insights into atpF function.
Correlating in vitro and in vivo findings in ATP synthase studies presents significant challenges that researchers must address through careful experimental design and interpretation:
Major Correlation Challenges:
Environmental Differences:
In vitro systems lack the complex physiological environment of living bacteria
Intracellular conditions during infection (pH, ion concentrations) are difficult to replicate
Membrane composition affects ATP synthase function but differs between in vitro and in vivo settings
Regulatory Network Complexity:
Technical Limitations:
In vitro measurements often require non-physiological conditions
ATP synthase modifications for in vitro studies may alter natural function
Signal-to-noise ratio challenges in measuring activities in whole cells
Bridging Strategies:
Graduated Complexity Approach:
Parallel Measurements:
Develop compatible assays for both settings
Measure same parameters (e.g., ATP levels, proton translocation)
Use consistent environmental conditions where possible
Genetic Validation Approaches:
Create precise genetic modifications based on in vitro findings
Test phenotypic effects in bacterial cultures and infection models
Use complementation studies to confirm specificity
Previous research demonstrated how a systematic approach can bridge in vitro and in vivo findings. MgtC was shown to inhibit ATP synthase activity in inverted membrane vesicles, and corresponding phenotypes (altered ATP levels and cytoplasmic pH) were observed in whole bacteria. The N92T mutation in MgtC disrupted both the in vitro interaction and in vivo phenotypes, providing strong correlative evidence .
Distinguishing direct effects on ATP synthase function from indirect metabolic consequences when studying atpF requires a multi-faceted approach:
Diagnostic Experimental Designs:
Immediate vs. Delayed Effects:
Direct effects manifest immediately upon perturbation
Indirect effects appear after metabolic adjustments
Time-course studies can differentiate these patterns
Isolated Systems Analysis:
Study effects in purified ATP synthase complexes
Test in membrane vesicles where metabolic networks are disrupted
Compare to whole-cell phenomena to identify discrepancies
Genetic Approach:
Create specific point mutations in atpF
Engineer compensatory mutations in interaction partners
Suppressor mutation analysis can identify functional relationships
Metabolic Network Control:
Measure effects under different carbon sources
Control electron transport chain activity
Use metabolic inhibitors to block specific pathways
Analytical Framework:
| Parameter | Direct Effect Signature | Indirect Effect Signature | Verification Method |
|---|---|---|---|
| ATP synthesis rate | Immediate change upon atpF mutation | Gradual change as metabolism adjusts | Time-course analysis |
| Proton translocation | Directly impaired by structural changes | Minimally affected by metabolic changes | Membrane vesicle assays |
| Complex assembly | Visibly altered complex formation | Normal complex with altered regulation | Blue Native PAGE |
| Protein interactions | Changed interaction with ATP synthase subunits | Changed interactions with metabolic enzymes | Co-immunoprecipitation |
| Metabolite profiles | Limited changes beyond ATP/ADP ratio | Broad changes across central metabolism | Metabolomics analysis |
Specialized Techniques:
Direct Interaction Assessment:
Site-specific cross-linking to identify precise interaction points
FRET-based approaches to measure conformational changes
Hydrogen-deuterium exchange mass spectrometry to map interaction surfaces
Real-time Activity Monitoring:
This systematic approach helps researchers trace the causal chain from atpF modifications to observed phenotypes, distinguishing primary effects from secondary adaptations.
ATP synthase subunit b represents a promising target for novel antimicrobial development through several strategic approaches:
Therapeutic Targeting Rationales:
Essential Function:
Structural Vulnerability:
Subunit b forms a critical part of the stator that stabilizes the complex
Targeting could disrupt the conformational coupling mechanism
May be more accessible than catalytic sites within the membrane
Specificity Potential:
Structural differences between bacterial and human ATP synthases
Potential for selective targeting to minimize host toxicity
Salmonella-specific features could enable narrow-spectrum activity
Intervention Approaches:
Small Molecule Inhibitors:
Design molecules that disrupt subunit b interactions with other complex components
Target the interface between subunit b and the F1 sector
Focus on regions unique to bacterial ATP synthases
Peptide-based Therapeutics:
Develop peptides mimicking interaction domains
Create cell-penetrating peptides targeting specific subunit b regions
Engineer peptides that compete with natural binding partners
Allosteric Modulation:
Identify allosteric sites that affect conformational dynamics
Design molecules that lock subunit b in non-functional conformations
Target sites that prevent proper energy coupling
Drug Development Considerations:
| Approach | Advantages | Challenges | Research Priorities |
|---|---|---|---|
| Active site inhibitors | Direct functional inhibition | Less specificity potential | Structural characterization of catalytic mechanism |
| Stator disruptors | Unique targeting opportunity | Delivery to membrane-embedded target | Detailed stator assembly mechanism |
| Allosteric inhibitors | Potential for high specificity | Complex structure-function relationship | Identification of regulatory binding sites |
| Complex assembly inhibitors | Prevent functional complex formation | Requires understanding of assembly process | Characterization of assembly intermediates |
This approach leverages the critical role of ATP synthase in bacterial bioenergetics while exploiting structural and functional features for selective targeting.